Evidence map›Paper›PMID 7762562›Full record

ArticleAmerican journal of human genetics1995

Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.

B Morrow, R Goldberg, C Carlson, R Das Gupta, H Sirotkin, J Collins, I Dunham, H O'Donnell, P Scambler, R Shprintzen

Open access · greenAbstract read
In one paragraph

Article in American journal of human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 245 citations in OpenAlex.

  1. Trial
  2. Article
  3. Resolving the 22q11.2 deletion using CTLR-Seq reveals chromosomal rearrangement mechanisms and individual variance in breakpoints.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Specific differences in temporal binding aspects of the attentional blink in Chromosome 22q11.2 Deletion Syndrome.Cortex; a journal devoted to the study of the nervous system and behavior · 2018
    Article
  12. Molecular genetics of 22q11.2 deletion syndrome.American journal of medical genetics. Part A · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. 22q11.2 deletion syndrome.Nature reviews. Disease primers · 2015
    Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

B MorrowDepartment of Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
R Goldberg
C Carlson
R Das Gupta
H Sirotkin
J Collins
I Dunham
H O'Donnell
P Scambler
R Shprintzen
Yeshiva University · USAlbert Einstein College of Medicine · US

Funding

MOLECULAR ASPECTS OF VELO-CARDIO-FACIAL SYNDROMESR01HD031601 · NICHD · YESHIVA UNIVERSITY · PI KUCHERLAPATI, RAJU S · 1995 to 1996
–
NICHD NIH HHS R01HD31601
6 · The paper itself

Abstract

Velo-cardio-facial syndrome (VCFS) is a common genetic disorder among individuals with cleft palate and is associated with hemizygous deletions in human chromosome 22q11. Toward the molecular definition of the deletions, we constructed a physical map of 22q11 in the form of overlapping YACs. The physical map covers > 9 cM of genetic distance, estimated to span 5 Mb of DNA, and contains a total of 64 markers. Eleven highly polymorphic short tandem-repeat polymorphic (STRP) markers were placed on the physical map, and 10 of these were unambiguously ordered. The 11 polymorphic markers were used to type the DNA from a total of 61 VCFS patients and 49 unaffected relatives. Comparison of levels of heterozygosity of these markers in VCFS patients and their unaffected relatives revealed that four of these markers are commonly hemizygous among VCFS patients. To confirm these results and to define further the breakpoints in VCFS patients, 15 VCFS individuals and their unaffected parents were genotyped for the 11 STRP markers. Haplotypes generated from this study revealed that 82% of the patients have deletions that can be defined by the STRP markers. The results revealed that all patients who have a deletion share a common proximal breakpoint, while there are two distinct distal breakpoints. Markers D22S941 and D22S944 appear to be consistently hemizygous in patients with deletions. Both of these markers are located on a single nonchimeric YAC that is 400 kb long. The results also show that the parental origin of the deleted chromosome does not have any effect on the phenotypic manifestation.

Indexed as

Sequence DeletionAbnormalities, MultipleBase SequenceChromosome MappingChromosomes, Artificial, YeastChromosomes, Human, Pair 22DiGeorge SyndromeFaceFemaleGenetic MarkersGenotypeHeart Defects, CongenitalHumansMaleMolecular Sequence DataMouth AbnormalitiesGenetic Markers

Identifiers

PMID7762562
PMCPMC1801093
OpenAlexW1598485198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.